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α-Galactosylceramide (1) is known as the prototypical antigen 
for iNKT cells. Following complexation with the antigen 
presenting glycoprotein CD1d, α-GalCer is recognized by 
iNKT-cells, which, after activation, produce a rapid burst of 
Th1 and Th2 cytokines. The fact that both kinds of cytokines 
antagonize each other’s effect is seen as a considerable 
drawback for therapeutic applications. Hence, much research 
efforts are directed towards the identification of α-GalCer 
analogues capable of skewing the iNKT cell responses 
towards a more biased Th1 or Th2 profile. 
Based on the interesting Th1 biased in vivo response induced 
by analogue 2 and the recently obtained crystal structure of 
this compound complexed to mCD1d and the TCR
1
 we 
synthesized a diverse set of derivatives modified at the C-5” or 
C-6”-position of the galactopyranosyl ring.  
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